Thursday, April 07, 2005

Study shows new antipsychotic drug prevents brain loss in schizophrenia Columbia University College of Physicians and Surgeons press release at EurekAlert - "A new brain imaging study of recently diagnosed schizophrenia patients has found, for the first time, that the loss of gray matter typically experienced by patients can be prevented by one of the new atypical antipsychotic drugs, olanzapine, but not by haloperidol, an older, conventional drug. The study, published in today's Archives of General Psychiatry, also confirmed previous studies that show patients who experience less brain loss do better clinically..."